< Back to latest news & events

Event

OPT Congress – Cambridge

March 2019

Event date: 26th March 2019

HGF Patent Director Alison Gallafent will be presenting “siRNA science journey as reflected by the patent literature” at the 4th Annual Oligonucleotide & Precision Therapeautics March 26-28 2019 in Cambridge.

To complement the 4th annual Oligonucleotide Discover and Delivery conference there will also be a 2 day program dedicated to Oligonucleotide CMC and Regulatory Strategies plus two in-depth symposiums focusing on Drug Discovery for Rare Diseases and New Frontiers in Gene Editing and Repair.

The OPT congress brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to provide a unique opportunity to discuss advances in next generation oligonucleotide therapies throughout the drug development process.

Patent Director Alison Gallafent will be presenting “siRNA science journey as reflected by the patent literature”.

Starting with patents that initially reflected manufacturing constraints, moving to patents reflecting greater understanding of chemical modifications, and later product specific patents.  Advantages and potential challenges are associated with patent protection at the different stages of this journey.  Close interaction between Research and Attorney can help to address potential challenges.

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Celebrating exam success at HGF!

We are once again delighted to share that our colleagues have achieved success in their recent exams! Their dedication, perseverance, and commitment to professional development have paid off, and we …

Read article

Is the Supreme Court denial in Thatcher’s case a fatal blow against lookalikes?

The dispute between Thatcher’s Cider Company and Aldi Stores Limited has been long running and has sparked legal controversy along the way. On 4th June 2025 the Supreme denied Aldi …

Read article

HGF ranked among Europe’s top patent firms in IP STARS Patent Rankings 2025

HGF has once again made a bold mark in the latest Managing IP Stars 2025 firm rankings, with top-tier recognition across multiple jurisdictions for our patent expertise. This year’s results …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article